A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis -- Mitchell et al. 72 (1): 14 -- Neurology
R. M. Mitchell, BS, W. M. Freeman, PhD, W. T. Randazzo, BS, H. E. Stephens, MA, J. L. Beard, PhD, Z. Simmons, MD and J. R. Connor, PhD From the Departments of Neurosurgery (R.M.M., W.T.R., J.R.C.), Pharmacology (W.M.F.), and Neurology (H.E.S., Z.S.), George M. Leader Family Laboratory, Pennsylvania State University College of Medicine/Milton S. Hershey Medical Center, Hershey; and Department
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial -- Sorenson et al. 71 (22): 1770 -- Neurology
E. J. Sorenson, MD, A. J. Windbank, MD, J. N. Mandrekar, PhD, W. R. Bamlet, MS, S. H. Appel, MD, C. Armon, MD, P. E. Barkhaus, MD, P. Bosch, MD, K. Boylan, MD, W. S. David, MD, PhD, E. Feldman, MD, PhD, J. Glass, MD, L. Gutmann, MD, J. Katz, MD, W. King, PT, C. A. Luciano, MD, L. F. McCluskey, MD, S. Nash, MD, D. S. Newman, MD, R. M. Pascuzzi, MD, E. Pioro, MD, DPhil, FRCP, L.
1
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
http://www.neurology.org/cgi/content/short/72/4/317?rss=1